Abstract:The worldwide emergence of New Delhi metallo-b-lactamase (NDM) is of great concern. NDM could hydrolyze almost all b-lactam antibiotics, compromising antimicrobial treatments for patients with severe infection (1). Few NDM inhibitors are effective for treating infection caused by carbapenem-resistant bacteria, and no promising compounds have been developed in the process as future NDM inhibitors (2). To the best of our knowledge, no report of a naturally inactivated blaNDM gene has been described so far. In this study, we identified a novel mutation in the promoter of IncX3-plasmid-carrying blaNDM-5 that leads to the reduction of carbapenems resistance in a clinical Escherichia coli strain. The E. coli isolate Z503 was cultured from a fecal sample of a female patient in Zhejiang in 2018, using enrichment media supplemented with meropenem (0.25 mg/mL), and further confirmed by 16S rRNA gene sequencing. The presence of gene blaNDM-5 was screened by PCR, as described previously (3). NDM-producing Escherichia coli strains are usually associated with medium to high MIC for carbapenems. Interestingly, strain Z503 shows low resistance to meropenem (MIC = 1 mg/mL) and imipenem (MIC = 2 mg/mL), with MICs that remained within the susceptibility range. Whole-genome sequencing (WGS) of Z503 was performed using Illumina Hiseq2500 platform (Bionova) and Nanopore MinION sequencing platform (Oxford Nanopore Technologies). The whole-genome sequencing data were analyzed using multiple programs, including Unicycler (assembly), Prokka (annotation), and SRST2 (antibiotic resistance gene analysis) (3–5). WGS revealed that E. coli Z503 harbored a 4.27-Mb circular chromosome and four plasmids, including IncX3 (;46 kb), IncFIB (;47 kb), IncFII (;83 kb), and colRNA (;5 kb) type plasmids. The blaNDM-5 gene was located on an IncX3 type plasmid, namely, p503-IncX3 (;46 kb), which showed 98.61% identity to plasmid p3R-IncX3 (a blaNDM-5-carrying IncX3plasmid identified in our previous study) (accession number CP049352). In addition to blaNDM-5, blaTEM-98 (extended-spectrum b-lactamase [ESBL]-encoding gene), ampC1 and mrdA (b-lactam resistance genes), and 8 other antimicrobial resistant genes were identified in E. coli Z503. To investigate the conjugation efficiency of the p503-IncX3 plasmid, we mixed donor stain Z503 and recipient J53 at a ratio of 1:3 on LB agar and cultured them overnight. The mixtures were plated on LB agar containing meropenem (0.25 mg/mL) and sodium azide (150 mg/mL). The recombinant strains were confirmed by PCR-based screening. The plasmid p503-IncX3 could be successfully transferred at a high frequency (2.16 3.0) 1021, and the meropenem MIC of transconjugants was only 0.5mg/mL. The blaNDM-containing sequences identified share two common features. The upstream of blaNDM is always the insertion sequence ISAba125, while the downstream is always the bleomycin-resistant gene bleMBL (1). The insertion sequence ISAba125 plays a key role in the mobilization of NDM (6, 7). A group of genes were located downstream of bleMBL, including trpF, dsbC, and cutA (1). Similar genetic context was found in E. coli Z503 in this study, with 99.96% homology to the corresponding sequences in plasmid p3R-IncX3 and its similar variants, which has been widely reported worldwide (Fig. 1a). Notably, a single Editor Aude A. Ferran, INTHERES Copyright © 2022 Li et al. This is an openaccess article distributed under the terms of the Creative Commons Attribution 4.0 International license. Address correspondence to Shaolin Wang, shaolinwang@cau.edu.cn. The authors declare no conflict of interest. Published 9 February 2022

The effects of NDM-5 on Escherichia coli and the screening of interacting proteins

Dissemination of bla NDM-5 gene via an IncX3-type plasmid among non-clonal Escherichia coli in China

Detection of an Escherichia coli Sequence Type 167 Strain with Two Tandem Copies of blaNDM-1 in the Chromosome.

NDM Metallo-β-Lactamases and Their Bacterial Producers in Health Care Settings

High Incidence and Endemic Spread of NDM-1-Positive Enterobacteriaceae in Henan Province, China

Discovery and Characterisation of an Escherichia Coli ST206 Strain Producing NDM-5 and MCR-1 from a Patient with Acute Diarrhoea in China.

Bla(ndm-21), a New Variant of Bla(ndm) in an Escherichia Coli Clinical Isolate Carrying Bla(ctx-M-55) and Rmtb

A Natural Novel Mutation in the Bla NDM-5 Promoter Reducing Carbapenems Resistance in a Clinical Escherichia Coli Strain

Unveiling the genetic architecture and transmission dynamics of a novel multidrug-resistant plasmid harboring blaNDM-5 in E. Coli ST167: implications for antibiotic resistance management

Novel Variant of New Delhi Metallo-β-lactamase, NDM-20, in Escherichia Coli.

Resistance mechanism and molecular epidemiology of the New Delhi metallo-β-lactamase-1 possessing Klebsiella pneumoniae

Molecular Basis Of Ndm-1, A New Antibiotic Resistance Determinant

A Natural Novel Mutation in the blaNDM-5 Promoter Reducing Carbapenems Resistance in a Clinical Escherichia coli Strain

Distribution and molecular epidemiology of New Delhi metallo-β-lactamase variants in carbapenem-resistant Enterobacteriaceae

Cloning and Expressing of the bla(NDM-1) Gene in Escherichia co li and Drug Resistance Detection

Decoding the enigma: unveiling the transmission characteristics of waterfowl-associated blaNDM-5-positive Escherichia coli in select regions of China

Oligopeptides As Full-Length New Delhi Metallo-Β-lactamase-1 (NDM-1) Inhibitors.

Genetic and Enzymatic Characterization of Two Novel Blandm-36, -37 Variants in Escherichia Coli Strains

A Structural View of the Antibiotic Degradation Enzyme NDM-1 from a Superbug

Plasmid-Mediated Novel Blandm-17 Gene Encoding a Carbapenemase with Enhanced Activity in a Sequence Type 48 Escherichia Coli Strain.

Recent research and development of NDM-1 inhibitors